SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-117737
Filing Date
2021-04-15
Accepted
2021-04-15 16:07:03
Documents
3
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d126447ddef14a.htm DEF 14A 317602
2 GRAPHIC g126447g06v16.jpg GRAPHIC 75536
3 GRAPHIC g126447g48q31.jpg GRAPHIC 82998
  Complete submission text file 0001193125-21-117737.txt   526473
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38997 | Film No.: 21828565
SIC: 2834 Pharmaceutical Preparations